Skip to main content

Acid Reflux

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ono Pharmaceutical
Ono PharmaceuticalJapan - Osaka
1 program
1
ONO-8539Phase 11 trial
Active Trials
NCT01705275Completed20
Norgine
NorgineAustria - Vienna
1 program
1
ZegeridPhase 11 trial
Active Trials
NCT01710995Completed20Est. Feb 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ono PharmaceuticalONO-8539
NorgineZegerid

Clinical Trials (2)

Total enrollment: 40 patients across 2 trials

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

Start: Jan 201320 patients
Phase 1Completed

A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

Start: Oct 2010Est. completion: Feb 201120 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.